A Deeper Look into Low Dose Naltrexone (LDN): Research & Insights
Naltrexone is an opiate receptor antagonist. The 50-mg dose of Naltrexone was approved by the FDA for opioid and alcohol addiction in 1984. At much lower doses (0.5–9 mg per day), it may provide relief to patients suffering from autoimmune diseases, chronic pain, mental health diseases, and inflammation.
Low Dose Naltrexone: A Medical Game Changer
ScriptWorks has spent hours and hours researching and collaborating with healthcare professionals on Low Dose Naltrexone since 2014. Doctors and pharmacists around the world continue to study this fascinating therapy.